Key Developments: STAAR Surgical Co (STAA.W)
8.76USD
24 May 2013
$0.03 (+0.34%)
$8.73
$8.70
$8.76
$8.53
500
539
$9.42
$4.99
Latest Key Developments (Source: Significant Developments)
Staar Surgical Co Issues FY 2013 Revenue Guidance In Line With Analysts' Estimates-Conference Call
Staar Surgical Co announced that for fiscal 2013, it expects total revenue growth in the range of 8% to 10%. The Company reported revenues of $63.78 in fiscal 2012. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $69.89 million for fiscal 2013. Full Article
Staar Surgical Co Issues Q1 2013 Revenue Guidance Above Analysts' Estimates
Staar Surgical Co announced that for the first quarter of 2013, it expects revenue to be approximately $18 million. According to I/B/E/S Estimates, analysts were expecting the Company to report revenue of $17 million for the first quarter of 2013. Full Article
Staar Surgical Co Comments On Q4 2012 Revenue Guidance; Reaffirms H2 2012 Revenue Guidance-Conference Call
Staar Surgical Co announced that for the fourth quarter of 2012, it expects to exceed third quarter of 2012 revenue growth rate. For the second half of 2012, it expects growth to be short of this double-digit objective. The Company reported revenue of $15.87 million in third quarter of 2012. According to I/B/E/S Estimates, analysts were expecting the Company to report revenue of $18.63 million for the fourth quarter of 2012. Full Article
Staar Surgical Co Comments On H2 2012 Revenue Guidance; Reaffirms FY 2014 Revenue Guidance-Conference Call
Staar Surgical Co announced that for the second half of 2012, it expects revenues to grow by double digits. For fiscal 2014, it expects revenues to be approximately $100 million. According to I/B/E/S Estimates, analysts were expecting the Company to report revenue of $16.78 million for the third quarter of 2012 and revenue of $18.64 million for the fourth quarter of 2012. Full Article
STAAR Surgical Co. Issues FY 2014 Revenue Guidance Above Analysts' Estimates-Conference Call
STAAR Surgical Co. announced that for fiscal 2014, it expects revenues to be over $100 million. According to I/B/E/S Estimates, analysts were expecting the Company to report revenue of $90 million for fiscal 2014. Full Article
STAAR Surgical Co. Issues Q2 2012 Revenue Guidance Below Analysts' Estimates
STAAR Surgical Co. announced that for the second quarter of 2012, it expects total revenue is to be approximately $16 million. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $18 million for the second quarter of 2012. Full Article
STAAR Surgical Co. Reaffirms FY 2012 Guidance
STAAR Surgical Co. reaffirmed its key target metrics for fiscal 2012. For fiscal 2012, the Company expects increase in revenues of 15% and profitable each quarter and for fiscal 2012. The Company reported revenue of $62.77 million in fiscal 2011. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $72.89 million and net income of $3.14 million for fiscal 2012 Full Article
STAAR Surgical Co. Announces Visian Toric ICL Approved To Market In Japan
STAAR Surgical Co. announced that its Visian Toric Implantable Collamer Lens has been approved by the Japanese Ministry of Health, Labor and Welfare. With this approval, the Company is able to expand its product offerings to include the Toric ICL in Japan. Full Article
STAAR Surgical Co. Receives CE Mark Approval To Market Toric Collamer IOL In Europe
STAAR Surgical Co. announced that it has received CE Mark approval for nanoFLEX Toric Collamer Single Piece IOL. The CE Mark approval of the nanoFLEX Toric IOL will allow the Company to expand product offerings in the European Union (EU) to include an improved solution for cataract patients with astigmatism. The nanoFLEX Toric IOL was approved for correction of 1.0 diopters to 4.0 diopters of cylinder in 0.5 diopter steps. The Company received CE Mark approval for its nanoFLEX IOL in April 2011 and began shipments in the third quarter of 2011. Full Article
STAAR Surgical Co. Issues Q3 2011 Revenue Guidance Below Analysts' Estimates
STAAR Surgical Co. announced the for the third quarter of 2011, it expects revenue to be $15.3 million. According to I/B/E/S Estimates, analysts were expecting the Company to report revenue of $15.13 million for the third quarter of 2011. Full Article
Earnings vs. 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
